Vos AG[au] - Search Results

Year	Number of Results
2004	1
2012	3
2013	2
2016	1
2017	1
2018	1
2019	6
2020	7
2021	7
2022	6
2023	1
2024	0

1

Cardiovascular toxicity of contemporary antiretroviral therapy.

Vos AG, Venter WDF. Vos AG, et al. Curr Opin HIV AIDS. 2021 Nov 1;16(6):286-291. doi: 10.1097/COH.0000000000000702. Curr Opin HIV AIDS. 2021. PMID: 34545036 Review.

2

[Mycoplasma-pneumoniae-associated mucositis].

Vos AG, Goossens MH, Thijsen SF, Sankatsing SU. Vos AG, et al. Ned Tijdschr Geneeskd. 2013;157(42):A6375. Ned Tijdschr Geneeskd. 2013. PMID: 24128598 Dutch.

3

Tuberculosis treatment and resulting abnormal blood glucose: a scoping review of studies from 1981 - 2021.

Williams V, Onwuchekwa C, Vos AG, Grobbee DE, Otwombe K, Klipstein-Grobusch K. Williams V, et al. Among authors: vos ag. Glob Health Action. 2022 Dec 31;15(1):2114146. doi: 10.1080/16549716.2022.2114146. Glob Health Action. 2022. PMID: 36178364 Free PMC article. Review.

4

Obesity and the heart: The impact of obesity beyond the body mass index.

Vos AG. Vos AG. Eur J Prev Cardiol. 2020 Dec;27(18):2004-2005. doi: 10.1177/2047487319897170. Epub 2020 Jan 16. Eur J Prev Cardiol. 2020. PMID: 31948279 Free PMC article. No abstract available.

5

Pro-Inflammatory Markers in Relation to Cardiovascular Disease in HIV Infection. A Systematic Review.

Vos AG, Idris NS, Barth RE, Klipstein-Grobusch K, Grobbee DE. Vos AG, et al. PLoS One. 2016 Jan 25;11(1):e0147484. doi: 10.1371/journal.pone.0147484. eCollection 2016. PLoS One. 2016. PMID: 26808540 Free PMC article. Review.

6

Association between Immune Markers and Surrogate Markers of Cardiovascular Disease in HIV Positive Patients: A Systematic Review.

Vos AG, Hulzebosch A, Grobbee DE, Barth RE, Klipstein-Grobusch K. Vos AG, et al. PLoS One. 2017 Jan 13;12(1):e0169986. doi: 10.1371/journal.pone.0169986. eCollection 2017. PLoS One. 2017. PMID: 28085961 Free PMC article. Review.

7

The influence of smoking and HIV infection on pulmonary function.

Sussenbach AE, van Gijzel SWL, Lalla-Edward ST, Venter WDF, Shaddock E, Feldman C, Klipstein-Grobusch K, Vos AG. Sussenbach AE, et al. Among authors: vos ag. South Afr J HIV Med. 2022 Feb 21;23(1):1329. doi: 10.4102/sajhivmed.v23i1.1329. eCollection 2022. South Afr J HIV Med. 2022. PMID: 35284096 Free PMC article.

8

The value of geriatric assessments in predicting treatment tolerance and all-cause mortality in older patients with cancer.

Hamaker ME, Vos AG, Smorenburg CH, de Rooij SE, van Munster BC. Hamaker ME, et al. Among authors: vos ag. Oncologist. 2012;17(11):1439-49. doi: 10.1634/theoncologist.2012-0186. Epub 2012 Aug 31. Oncologist. 2012. PMID: 22941970 Free PMC article. Review.

9

Comparative performance of cardiovascular risk prediction models in people living with HIV.

Tahir IS, Vos AG, Damen JAA, Barth RE, Tempelman HA, Grobbee DE, Scheuermaier K, Venter WDF, Klipstein-Grobusch K. Tahir IS, et al. Among authors: vos ag. South Afr J HIV Med. 2022 Nov 15;23(1):1395. doi: 10.4102/sajhivmed.v23i1.1395. eCollection 2022. South Afr J HIV Med. 2022. PMID: 36479421 Free PMC article.

10

Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review.

Hamaker ME, Jonker JM, de Rooij SE, Vos AG, Smorenburg CH, van Munster BC. Hamaker ME, et al. Among authors: vos ag. Lancet Oncol. 2012 Oct;13(10):e437-44. doi: 10.1016/S1470-2045(12)70259-0. Lancet Oncol. 2012. PMID: 23026829 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

34 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year